» Articles » PMID: 36362337

MiR-23b-3p, MiR-124-3p and MiR-218-5p Synergistic or Additive Effects on Cellular Processes That Modulate Cervical Cancer Progression? A Molecular Balance That Needs Attention

Overview
Journal Int J Mol Sci
Publisher MDPI
Date 2022 Nov 11
PMID 36362337
Authors
Affiliations
Soon will be listed here.
Abstract

In cervical cancer (CC), miR-23b-3p, miR-124-3p, and miR-218-5p have been found to act as tumor suppressors by regulating cellular processes related to progression and metastasis. The objective of the present review is to provide an update on the experimental evidence about the role of miR-23b-3p, miR-124-3p, and miR-218-5p in the regulation of CC progression. Additionally, we present the results of a bioinformatic analysis that suggest that these miRNAs have a somewhat redundant role in the same cellular processes that may result in a synergistic effect to promote CC progression. The results indicate that specific and common target genes for miR-23b-3p, miR-124-3p, and miR-218-5p regulate proliferation, migration, apoptosis, and angiogenesis, all processes that are related to CC maintenance and progression. Furthermore, several target genes may regulate cancer-related signaling pathways. We found that a total of 271 proteins encoded by the target mRNAs of miR-23b-3p, miR-124-3p, or miR-218-5p interact to regulate the cellular processes previously mentioned, and some of these proteins are regulated by HPV-16 E7. Taken together, information analysis indicates that miR-23b-3p, miR-124-3p, and miR-218-5p may potentiate their effects to modulate the cellular processes related to the progression and maintenance of CC with and without HPV-16 involvement.

Citing Articles

miR-218-5p, miR-124-3p and miR-23b-3p act synergistically to modulate the expression of NACC1, proliferation, and apoptosis in C-33A and CaSki cells.

Romero-Lopez M, Jimenez-Wences H, Cruz-De la Rosa M, Alarcon-Millan J, Mendoza-Catalan M, Ortiz-Sanchez E Noncoding RNA Res. 2024; 9(3):720-731.

PMID: 38577025 PMC: 10990753. DOI: 10.1016/j.ncrna.2024.02.016.


lncRNA TUSC7 regulates oxidative stress level by targeting miR-23b in colorectal cancer and thus inhibits cell proliferation, migration and invasion.

Ye H, Ren W, Liu G, Guo Q Aging (Albany NY). 2023; 15(23):13876-13887.

PMID: 38054829 PMC: 10756093. DOI: 10.18632/aging.205270.


Function of microRNA‑124 in the pathogenesis of cancer (Review).

Liu Y, Yang Y, Wang X, Yin S, Liang B, Zhang Y Int J Oncol. 2023; 64(1).

PMID: 38038165 PMC: 10705041. DOI: 10.3892/ijo.2023.5594.


Tumor suppressor miR-218 directly targets epidermal growth factor receptor (EGFR) expression in triple-negative breast cancer, sensitizing cells to irradiation.

Wischmann F, Troschel F, Frankenberg M, Kemper B, Vijaya Kumar A, Sicking M J Cancer Res Clin Oncol. 2023; 149(11):8455-8465.

PMID: 37088795 PMC: 10374822. DOI: 10.1007/s00432-023-04750-x.

References
1.
Campos-Viguri G, Jimenez-Wences H, Peralta-Zaragoza O, Torres-Altamirano G, Soto-Flores D, Hernandez-Sotelo D . miR-23b as a potential tumor suppressor and its regulation by DNA methylation in cervical cancer. Infect Agent Cancer. 2015; 10:42. PMC: 4663735. DOI: 10.1186/s13027-015-0037-6. View

2.
Zhang X, Cai D, Meng L, Wang B . MicroRNA-124 inhibits proliferation, invasion, migration and epithelial-mesenchymal transition of cervical carcinoma cells by targeting astrocyte-elevated gene-1. Oncol Rep. 2016; 36(4):2321-8. DOI: 10.3892/or.2016.5025. View

3.
Liu B, Tian Y, Li F, Zhao Z, Jiang X, Zhai C . Tumor-suppressing roles of miR-214 and miR-218 in breast cancer. Oncol Rep. 2016; 35(6):3178-84. PMC: 4869936. DOI: 10.3892/or.2016.4749. View

4.
Ma C, Zeng C, Jin L, Yang Y, Li P, Chen L . GSK3β mediates the carcinogenic effect of HPV16 in cervical cancer. Sci Rep. 2015; 5:16555. PMC: 4642308. DOI: 10.1038/srep16555. View

5.
Yan L, Huang H, Zhang Y, Yuan X, Yan Z, Cao C . Involvement of p53-dependent apoptosis signal in antitumor effect of Colchicine on human papilloma virus (HPV)-positive human cervical cancer cells. Biosci Rep. 2020; 40(3). PMC: 7098170. DOI: 10.1042/BSR20194065. View